bf/NASDAQ:IMMX_icon.jpeg

COM:IMMIXBIO

Immix Biopharma, Inc.

  • Stock

2.04

−3.32%

−0.67

USD last updated 27/07 01:24:49

Last Close

2.71

25/07 20:00

Market Cap

56.87M

Beta: -

Volume Today

276.22K

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstre...Show More